
Published Oct 8, 2026 · Updated Oct 8, 2026
Do GLP‑1 Patches Work? What Patches and Supplements Can and Can't Do
GLP-1 patches and supplements are not GLP-1 medicines. Learn the red flags on a GLP-1 patch label, what the FTC says, and which real GLP-1 pills exist.
Short answer: no evidence shows that "GLP-1 patches" cause weight loss, and the Federal Trade Commission says flatly that nothing you wear or apply to your skin will make you lose weight.1 Patches and supplements sold with "GLP-1" on the label are not GLP-1 drugs. Real GLP-1 medicines exist as injections and as FDA-approved tablets, and every one of them requires a prescription.91116
Do GLP‑1 patches work?
No. There is no published clinical evidence that a GLP-1 patch produces meaningful weight loss. The FTC lists "lose weight with this patch or cream" among the weight-loss promises that are always false.1 It has acted against patch sellers before: in 2007 it banned one manufacturer from selling weight-loss patches and from claiming that a product worn or rubbed on the skin causes weight loss.2
Most patches marketed under the GLP-1 name contain plant extracts or supplement ingredients, not a GLP-1 drug. Approved GLP-1 medicines such as Wegovy, Rybelsus and Foundayo come as injections or tablets, not patches.101213
Why a supplement is not a GLP‑1 medicine
A dietary supplement is not reviewed by the FDA for safety or effectiveness before it is sold, and it may not claim to treat a disease. The FDA states that it does not have the authority to approve dietary supplements before they are marketed.3 A product sold as a supplement but represented as treating, preventing or curing a disease meets the legal definition of a drug and is regulated as one.3
GLP-1 drugs are different. They are prescription medicines approved on the strength of clinical trials, and the FDA's advice is to get them with a prescription from a clinician, filled at a state-licensed pharmacy.16
The FDA has also acted against products that blur the line. In December 2024 it warned a seller of unapproved oral GLP-1 products, including one that claimed to be FDA-approved.4
Red flags on a "GLP‑1" product label
A few claims reliably signal a product that is not what it says. Based on the FTC's and FDA's published positions, be wary of any product that:
- promises weight loss from something worn or applied to the skin, or weight loss without changing diet or exercise — claims the FTC says are always false;1
- says it treats, prevents or cures obesity or diabetes, which would make it an unapproved drug rather than a supplement;3
- claims to be FDA-approved while being sold without a prescription, as one oral GLP-1 product warned by the FDA did;4
- is sold as real semaglutide or tirzepatide but labeled "for research purposes" or "not for human consumption." The FDA has warned sellers of such products, including unapproved semaglutide, tirzepatide and retatrutide.416
How GLP‑1 works in the body
GLP-1 is a hormone made by cells in the gut and released after you eat. It stimulates insulin, holds back glucagon, slows the movement of food through the gut and appears to help regulate appetite.5
The body's own GLP-1 is broken down extremely quickly by an enzyme called DPP-4, much of it before it even leaves the gut.5 That is the key reason "natural GLP-1 boosting" is a different thing from a GLP-1 medicine: the drugs are engineered to act long enough to be taken once a week or once a day.1012
Best GLP‑1 supplements: what the evidence says about berberine
Berberine is the supplement most often sold as "nature's GLP-1," and the measured weight effect is small.
- A 2020 meta-analysis of 12 randomized trials found berberine reduced body weight by an average of about 2.07 kg compared with control.6
- A 2026 meta-analysis of 23 trials found an average reduction of 0.88 kg, and called for better reporting of the purity and potency of the berberine used.7
For scale, approved GLP-1 drugs in their trials produced average losses measured in percent of body weight — for example 13.6% with oral semaglutide 25 mg over 64 weeks.14
Supplement quality is a second problem. When researchers tested 15 berberine supplements bought in the US, the average content was 75% of what the label claimed, ranging from 33% to 100%, and 9 of the 15 failed a standard pharmaceutical potency range. Price did not predict quality.8
Other ingredients sold as GLP-1 boosters — fibers, probiotics, plant extracts — are marketed with similar language. Because supplements are not approved before sale, the FDA has not evaluated these products for safety or effectiveness.3 There is no "best over the counter GLP-1 supplement" in the sense of a product proven to work like a GLP-1 drug.
How can I increase my GLP‑1 naturally?
Your body releases GLP-1 every time you eat, but there is no evidence that any food or supplement turns that into drug-level weight loss.5 The natural hormone is broken down extremely rapidly by DPP-4, which is why the medicines are designed to resist it.5
What has evidence for weight is the foundation every GLP-1 label is built on: the approved drugs are indicated in combination with a reduced-calorie diet and increased physical activity.1012 Those habits help with or without medication, and they are the part that does not stop when a prescription does.
FDA-approved GLP‑1 pills
Real GLP-1 tablets exist, and all of them are prescription-only.
- Wegovy tablets (semaglutide) were approved on December 22, 2025.9 They are taken once daily on an empty stomach with up to 4 ounces of water, at least 30 minutes before food or other medicines, starting at 1.5 mg and building to 25 mg.10 They are approved for weight reduction and for cardiovascular risk reduction in adults.10 In the OASIS 4 trial, oral semaglutide 25 mg produced an average weight change of −13.6% at 64 weeks, against −2.2% with placebo.14
- Foundayo (orforglipron) was approved on April 1, 2026.11 It is a once-daily GLP-1 receptor agonist that can be taken with or without food, starting at 0.8 mg and increased monthly up to a maximum of 17.2 mg.12 In the ATTAIN-1 trial of an investigational orforglipron formulation, the highest dose produced an average weight change of −11.2% at 72 weeks, against −2.1% with placebo.15
- Rybelsus (oral semaglutide) is a once-daily tablet approved for type 2 diabetes, not for weight management.13
These are the products people usually mean when they ask "do GLP-1 pills work." Our ranking of the best oral GLP-1 options compares how to get them.
Where can I buy GLP‑1 pills? Can you buy Ozempic over the counter?
No GLP-1 medicine is sold over the counter in the US. Ozempic, Wegovy, Rybelsus, Zepbound, Mounjaro and Foundayo all require a prescription, and the FDA advises getting a prescription from a clinician and filling it at a state-licensed pharmacy.16
A store shelf or website selling "GLP-1" without a prescription is selling a supplement, not the drug. Products labeled "for research purposes" or "not for human consumption" but sold for people to use are a separate risk the FDA has warned about, along with counterfeit Ozempic.16 For what to watch for, see our safety hub.
FAQ
Are GLP-1 patches FDA-approved? Approved GLP-1 drugs such as Wegovy, Rybelsus and Foundayo come as injections or tablets, not patches.101213 The FTC says nothing worn on the skin causes weight loss.1
Is berberine a natural GLP-1? No. It is a plant compound sold as a supplement. Meta-analyses find small average weight reductions of roughly 1 to 2 kg.67
Do GLP-1 supplements work like Ozempic? No supplement has shown weight loss comparable to approved GLP-1 drugs, and supplements are not reviewed for effectiveness before sale.314
Is there a GLP-1 pill for weight loss? Yes. Wegovy tablets and Foundayo are FDA-approved oral options for weight management, both by prescription.911
Can I get Ozempic without a prescription? No. Ozempic and every other GLP-1 drug are prescription medicines in the US.16
Next step
If you want an actual GLP-1 tablet rather than a supplement, our guide to the best oral GLP-1 providers compares prescription options for Wegovy tablets and Foundayo. For the injectable choices, see tirzepatide vs semaglutide, and for why cheaper pharmacy-made versions are restricted, compounded semaglutide.
This article is for information only and is not medical advice. GLP-1 medications are prescription drugs with real risks and side effects — talk to a licensed clinician before starting any treatment or supplement.
- 1.The truth behind weight loss adsThe FTC's list of weight-loss claims that are always false, including patches and creamsFederal Trade Commission↩
- 2.Weight-loss patch manufacturer banned from selling weight-loss patchesAugust 2007 settlement over claims that a product worn on the skin causes weight lossFederal Trade Commission↩
- 3.Questions and answers on dietary supplementsWhy supplements are not approved before sale and cannot claim to treat diseaseUS Food and Drug Administration↩
- 4.FDA Roundup, December 17, 2024Warning letters including one to a seller of unapproved oral GLP-1 productsUS Food and Drug Administration↩
- 5.The physiology of glucagon-like peptide 1Holst, on how the body makes GLP-1 and how quickly it is broken downPhysiological Reviews, via PubMed↩
- 6.The effect of berberine supplementation on obesity parametersAsbaghi et al., a meta-analysis of 12 randomized controlled trialsClinical Nutrition ESPEN, via PubMed↩
- 7.The effect of berberine on obesity indices: a systematic review and meta-analysisElahi Vahed et al., 23 randomized controlled trialsInternational Journal of Obesity, via PubMed↩
- 8.Variability in potency among commercial preparations of berberineFunk et al., laboratory testing of 15 US supplementsJournal of Dietary Supplements, via PubMed↩
- 9.Wegovy (semaglutide) tablets, NDA 218316Approval record for the oral form of WegovyUS Food and Drug Administration, Drugs@FDA↩
- 10.Wegovy (semaglutide) injection and tablets prescribing informationTablet dosing, administration and indicationsDailyMed, US National Library of Medicine↩
- 11.Foundayo (orforglipron), NDA 220934Approval record for Lilly's once-daily oral GLP-1 receptor agonistUS Food and Drug Administration, Drugs@FDA↩
- 12.Foundayo (orforglipron) prescribing informationIndication, dose escalation and administrationDailyMed, US National Library of Medicine↩
- 13.Rybelsus (oral semaglutide) prescribing informationOnce-daily tablet for type 2 diabetes, NDA 213051US Food and Drug Administration, Drugs@FDA↩
- 14.Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4)Wharton et al., 64-week placebo-controlled trialNew England Journal of Medicine, via PubMed↩
- 15.Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment (ATTAIN-1)Wharton et al., 72-week trial in 3,127 adultsNew England Journal of Medicine, via PubMed↩
- 16.FDA's concerns with unapproved GLP-1 drugs used for weight lossPrescription advice, counterfeit and research-product warningsUS Food and Drug Administration↩
NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.